135 related articles for article (PubMed ID: 12416081)
1. [Letigen, insulin resistance and treatment of obesity--again].
Richelsen B
Ugeskr Laeger; 2002 Oct; 164(42):4944-5. PubMed ID: 12416081
[No Abstract] [Full Text] [Related]
2. [Letigen, insulin resistance and treatment of obesity].
Richelsen B
Ugeskr Laeger; 2002 Aug; 164(32):3794; author reply 3794. PubMed ID: 12362622
[No Abstract] [Full Text] [Related]
3. [Liberalized use of Letigen--how is the documentation?].
Astrup AV
Ugeskr Laeger; 2002 Oct; 164(42):4942-3; author reply 4943-4. PubMed ID: 12416080
[No Abstract] [Full Text] [Related]
4. [Obesity epidemic after Letigen].
von Eyben FE
Ugeskr Laeger; 2002 Dec; 164(49):5820. PubMed ID: 12523231
[No Abstract] [Full Text] [Related]
5. [Is Letigen really SO dangerous?].
Tuxen A
Ugeskr Laeger; 2003 Jan; 165(3):246-7. PubMed ID: 12555715
[No Abstract] [Full Text] [Related]
6. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
7. Dangerously revved. Ephedrine misuse poses health hazards.
Jones TL
Tex Med; 1996 May; 92(5):52-3. PubMed ID: 8775849
[No Abstract] [Full Text] [Related]
8. [Therapy of hypersomnia].
Sigwald J; Julou L; Bouttier D; Thomas J
Rev Neurol (Paris); 1967 Jun; 116(6):631-46. PubMed ID: 4390507
[No Abstract] [Full Text] [Related]
9. [Fatal poisoning with Letigen].
Kanstrup MH; Petersen AP
Ugeskr Laeger; 2003 Jan; 165(3):239-40. PubMed ID: 12555708
[TBL] [Abstract][Full Text] [Related]
10. Dependence and chronic psychosis with D-nor-pseudoephedrine.
Alevizos B
Eur Psychiatry; 2003 Dec; 18(8):423-5. PubMed ID: 14680722
[No Abstract] [Full Text] [Related]
11. [Fatal poisoning with Letigen].
Hedetoft C; Jensen CH; Christensen MR; Christensen O
Ugeskr Laeger; 1999 Dec; 161(50):6937-8. PubMed ID: 10643382
[TBL] [Abstract][Full Text] [Related]
12. Herbal simulation of ephedrine and caffeine in treatment of obesity.
Dulloo AG
Int J Obes Relat Metab Disord; 2002 May; 26(5):590-2. PubMed ID: 12032740
[No Abstract] [Full Text] [Related]
13. Ephedrine use is risky business.
Landry GL
Curr Sports Med Rep; 2003 Feb; 2(1):1-2. PubMed ID: 12831669
[No Abstract] [Full Text] [Related]
14. Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol.
Tormey WP; Bruzzi A
Med Sci Law; 2001 Oct; 41(4):331-6. PubMed ID: 11693229
[TBL] [Abstract][Full Text] [Related]
15. [Picture of the month: coronary arteriosclerosis].
Madsen SH; Kristensen IB; Rosendal I
Ugeskr Laeger; 2010 Mar; 172(12):971. PubMed ID: 20376981
[No Abstract] [Full Text] [Related]
16. Nonprescription appetite suppressants.
Drew R
N C Med J; 1983 Sep; 44(9):573-4. PubMed ID: 6579375
[No Abstract] [Full Text] [Related]
17. Ephedra in perspective--a current review.
Abourashed EA; El-Alfy AT; Khan IA; Walker L
Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
[TBL] [Abstract][Full Text] [Related]
18. Different caffeine preparations.
Rasmussen KG; Brink DD; Soine WH
Convuls Ther; 1996 Sep; 12(3):195-6. PubMed ID: 8872407
[No Abstract] [Full Text] [Related]
19. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids.
Berman JA; Setty A; Steiner MJ; Kaufman KR; Skotzko C
J Addict Dis; 2006; 25(3):45-8. PubMed ID: 16956868
[TBL] [Abstract][Full Text] [Related]
20. FDA proposes constraints on ephedrine dietary supplements.
Am J Health Syst Pharm; 1997 Jul; 54(14):1578. PubMed ID: 9248599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
